Australia, April 29 -- Pacira Pharmaceuticals Inc., owns the trademark (2588018) for 'EXPAREL' till Sept. 18, 2035.
Status: registered:
Registered/protected
Class: 5 [Analgesics; pharmaceutical preparations; chemical preparations and reagents for pharmaceutical, medical, and veterinary clinic purposes, namely, pharmaceutical preparations for acute care treatment, namely, for the monitoring and treatment of pain and cancer; pharmaceutical preparations for post-cosmetic surgery use; anesthetics for surgical and nonsurgical use; drug delivery agents in the form of an injectable suspension that facilitates the delivery of pharmaceutical preparations and analgesics; pharmaceutical products for the treatment of pain in joint disease; pharmaceutical preparations, namely, a corticosteroid for use in treatment of osteoarthritis pain; liposome formulations containing preparations and substances for use in anesthesia and for the treatment and control of pain]
Type of Mark: Word
Date of Acceptance: Oct. 31, 2025
Registration Advertised: April 28
For further details contact Griffith Hack.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2588018.
Disclaimer: Curated by HT Syndication.
